Robert E. Ward

Robert E. Ward

Director/Board Member at
Massachusetts High Technology Council, Inc.
68 year
Health Technology
Consumer Services
Transportation

Profile

Robert E.
Ward
currently works at Massachusetts High Technology Council, Inc., as Director and Antidote Therapeutics, Inc., as Director.
Mr. Ward also formerly worked at Radius Health, Inc., as President, Chief Executive Officer & Director from 2013 to 2017, Eloxx Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2017 to 2020, OncoSec Medical, Inc., as Independent Director from 2018 to 2021, Clarkson Plc, as Finance Director, Akari Therapeutics Plc, as Independent Director from 2016 to 2018, Harriman Biopartners LLC, as Managing Director from 2010 to 2011, AstraZeneca PLC, as Vice President-Strategy & External Alliances from 2011 to 2013, and NPS Pharmaceuticals, Inc., as Vice President-Corporate Development from 2006 to 2010.
Mr. Ward received his undergraduate degree from the University of California, Santa Barbara, graduate degree from New Jersey Institute of Technology, and graduate degree from The Johns Hopkins University School of Medicine.

Robert E. Ward active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -

Former positions of Robert E. Ward

CompaniesPositionEnd
ONCOSEC MEDICAL INCORPORATED Director/Board Member 23/11/2021
ELOXX PHARMACEUTICALS, INC. Chief Executive Officer 29/02/2020
AKARI THERAPEUTICS, PLC Director/Board Member 01/08/2018
RADIUS HEALTH, INC. Chief Executive Officer 17/07/2017
ASTRAZENECA PLC Corporate Officer/Principal 01/12/2013
See the detail of Robert E. Ward's experience

Training of Robert E. Ward

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Health Technology

Health Technology

Transportation

Consumer Services

Consumer Services

Technology Services

Consumer Services

Health Technology

Harriman Biopartners LLC

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Robert E. Ward
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!